 In our Clinical Research Services division, we undertake on behalf of  our clients all facets of clinical trial management from Phase I to IV. è See pages 4 and 5 for more information Clinical Research Services Over 20 years Ergomed has built  particular expertise in oncology,  neurology, immunology and the  development of orphan drugs. Ergomed Clinical Research Services  operates out of 16 offices across the  Northern Hemisphere from San Antonio,  US to T aipei, T aiwan and is conducting  clinical trials in 55 countries. AT A GLANCE è See pages 6 and 7 for more information Drug Safety and  Medical Information Through our subsidiary  PrimeVigilance, we offer the full  range of drug safety and medical  information services including adverse  event case processing, aggregate  reporting, risk management  plans, signal detection and audit. PrimeVigilance, including the  recently re-branded PharmInvent, is  a medically led organisation with a  passion for quality. This is reflected in  our exceptional client retention and  organic growth. SPECIALISED SERVICES   PROVIDER 3 Ergomed plc Annual Report and Accounts 2017 Financial statements Governance Strategic report Net Service  Revenue Clinical Research Services £22.2m £17.4m OUR PERFORMANCE  OUR GEOGRAPHICAL REACH New contracts won £54m in 2017 Order backlog £88m at year-end Drug Safety and   Medical Information Employees 700 + Active clients 200 CHAIRMAN’S STATEMENT FOCUSED ON STRATEGY 2017 saw continued very strong performance  for Ergomed in